115 related articles for article (PubMed ID: 8769395)
1. The relevance of somatostatin receptor expression in malignant lymphomas.
van den Anker-Lugtenburg PJ; Löwenberg B; Lamberts SW; Krenning EP
Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy in the staging of lymphomas.
Ivancević V; Wörmann B; Nauck C; Sandrock D; Munz DL; Hiddemann W; Emrich D
Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
5. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
6. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
van den Anker-Lugtenburg PJ; Krenning EP; Oei HY; Van Hagen MP; Gerrits CJ; Reubi JC; Lamberts SW; Löwenberg B
Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analogue scintigraphy of malignant lymphomas.
Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
[TBL] [Abstract][Full Text] [Related]
13. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
[TBL] [Abstract][Full Text] [Related]
14. Initial staging of lymphoma with octreotide and other receptor imaging agents.
Ferone D; Semino C; Boschetti M; Cascini GL; Minuto F; Lastoria S
Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
Mouratidis B; Gilday DL; Ash JM
Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
